# Jiangsu NHWA Pharmaceutical Co., Ltd. – FDA Inspection, Sep 1, 2023

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-nhwa-pharmaceutical-co-ltd/43d116a8-3621-494b-a7f9-15b919ca0790
Source feed: FDA_Inspections

> FDA inspection 1218183 of Jiangsu NHWA Pharmaceutical Co., Ltd., September 01, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218183
- Company Name: Jiangsu NHWA Pharmaceutical Co., Ltd.
- Inspection Date: 2023-09-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1087127 - 2019-04-05](https://www.keypedia.com/records/fda_inspections/jiangsu-nhwa-pharmaceutical-co-ltd/2b1249c1-70a2-4795-ba6b-b2cbf39b2784)
- FDA Inspection 979725 - 2016-05-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41)
- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)

Company: https://www.keypedia.com/companies/jiangsu-nhwa-pharmaceutical-co-ltd/7b3402dc-1e72-471c-ba50-33f225ac6625

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
